HyMedPoly Students Arrive at Lucideon
Lucideon has welcomed the first PhD researchers, Muhammad Maqbool and Agata Łapa, it is hosting under the EU funded HyMedPoly project. Both researchers are working on antimicrobial materials at Lucideon for 18 months before returning to the Institute of Biomaterials at the University of Erlangen-Nuremberg to complete their projects.
HyMedPoly has brought Lucideon together with 8 European partners to train a total of 15 PhD researchers in the development of drug-free antibacterial materials used for medical applications, such as wound care and implants. The collaboration has been awarded a €3.9m (£2.8m) grant by the European Commission and Lucideon will be hosting 7 of these researchers over the project.
Stuart Maclachlan, Head of R&D, Lucideon, said:
“HyMedPoly is tackling a serious issue for the medical industry as the overuse of some drugs is leading to resistance in bacteria, in the worst case this renders drugs useless to combat infections. The collaborative approach allows everyone to draw on each other’s knowledge and existing intellectual properties. The wide skill set is important as the technology will need to utilise chemical, electrochemical, topographical and physical attributes to give the best performance.”
Muhammad Maqbool, said:
“It’s great to be a part of this innovative project. The collaboration between industry and academia allows us great access to valuable knowledge and research to help develop our materials while ensuring that we take the project through to industrial application and not just concept.”
To find out more about the HyMedPoly project visit Lucideon’s website at www.lucideon.com/hymedpoly.
HyMedPoly received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie grant agreement No 643050